Floatz logo

Treosulfan

Myelodysplastic Syndrome

Masonic Cancer Center, University of MinnesotaSmall moleculePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
65/ 100
Competitive Position
73/ 100

Competitive context

314 Active assets in the Myelodysplastic Syndrome cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Sawa Ito, MD
Phase 4BB
Daunorubicin
OHSU Knight Cancer Institute
Phase 3BB
Anti-Thymoglobulin, Rabbit
Peking University First Hospital
Phase 2/3BB
Fludarabine
Sawa Ito, MD
Phase 4BB
Cytosin-Arabinosid
The First Affiliated Hospital of Soochow University
Phase 4BB

View all 50 →

Same molecule, other indications

Treosulfan is also rated in:

Lymphoblastic Leukemia, Acute, Childhood;Dormant
BB
Indicative ·
66 / 100
View asset →
acute biphenotypic leukemiaDormant
BB
Indicative ·
65 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →